Menu ×

HEALTHCARE & PHARMACEUTICAL

Faecal Calprotectin Testing Market Segmentation by Disease Type (Inflammatory Bowel Disease, Colorectal Cancer, Celiac Disease, and Others); by Patient Type (Geriatric, Pediatric, and Adult); and by End-User (Hospitals, Diagnostic Laboratories, Academics, Research Institutes, and Others) – Global Demand Analysis & Opportunity Outlook 2031

  • Text Size:

Extensive insights into the Growth of Faecal Calprotectin Testing Market amidst COVID-19

Get the detailed impact analysis of COVID-19 that has disrupted the entire world and affected many industries.

Request Insights


IN THE NEWS

  • March 16, 2022: Thermo Fisher Scientific to launch a new large-volume electroporation system for cell therapy developers to facilitate commercial manufacturing of clinical therapy systems.

  • January 22, 2022: Exelixis Inc. announced the successful results for Cabozantinib in combination with immunotherapies in patients with advanced colorectal cancer.

Global Faecal Calprotectin Testing Market Highlights over 2022 – 2031

The global faecal calprotectin testing market is estimated to grow at a CAGR of ~12% over the forecast period, i.e., 2022 – 2031. The growth of the market can be attributed to the increasing prevalence of colon rectum cancer, inflammatory bowel syndrome, and other gastrointestinal disorders, as faecal calprotectin test is used for the diagnosis of these diseases. According to the data by the World Health Organization (WHO) over 10 million people died due to cancer in 2020, up from 9.6 million in 2018. Moreover, there were 1.93 million new cases of colorectal cancers in 2020 globally. Additionally, colon and rectum cancer caused 916,000 deaths in 2020 itself. Moreover, increasing awareness amongst people regarding early diagnosis of diseases, along with growing investment in research activities are estimated to boost the market growth. As per the data by the World Bank, 2.203% of the global gross domestic product (GDP) was spent on R&D activities in 2018. Moreover, government initiatives to provide efficient healthcare to the people, along with increasing individual disposable income are anticipated to boost the market growth. 

Faecal Calprotectin Testing Market Graph

Get more information on this report: Request Sample PDF

The market is segmented by disease type into inflammatory bowel disease, colorectal cancer, celiac disease, and others, out of which, the colorectal cancer segment is anticipated to hold a substantial share in the global faecal calprotectin testing market over the forecast period on account of increasing cases of cancer, along with growing cancer awareness amongst people.

Major Macro-Economic Indicators Impacting the Market Growth

Global Healthcare Expenditure per Capita image

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Faecal Calprotectin Testing Market Regional Synopsis

On the basis of geographical analysis, the global faecal calprotectin testing market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in Asia Pacific region is estimated to witness noteworthy growth over the forecast period on the back of improving healthcare systems, along with high prevalence of gastrointestinal diseases in the region.

The market in the North America region is anticipated to gain the largest market share throughout the forecast period owing to the high incidences of colorectal cancer, celiac disease, and other disorders in the developed countries, backed by the unhealthy lifestyle of the population. As per the data by the Center for Disease Control and Prevention (CDC), about 1 in 23 men and 1 in 25 women have the risk of colorectal cancer in the U.S. 

Faecal Calprotectin Testing Market Share Graph

Get more information on this report: Request Sample PDF

The global faecal calprotectin testing market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global faecal calprotectin testing market includes the following segments:

By Disease Type

By Patient Type

  • Geriatric
  • Pediatric
  • Adult

By End-User

  • Hospitals
  • Diagnostic Laboratories
  • Academics
  • Research Institutes
  • Others

Growth Drivers

  • Increasing Prevalence of Colorectal Cancer
  • Rising Awareness amongst People for Early Diagnosis

Challenges

  • Lack of Researchers and Practitioners in Pathology

Top Featured Companies Dominating the Market

  • Exelixis Inc.
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis 
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • Abbexa Limited
  • Bioserv Diagnostics Gmbh
  • Epitope Diagnostics, Inc.
  • LifeSpan BioSciences, Inc.
  • RayBiotech, Inc.

FREQUENTLY ASKED QUESTIONS


Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved